Stocks
ABIO Financial Statements (ABIO) |
||||||||||
| Артген биотех (ИСКЧ)smart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 08.05.2020 | 30.04.2021 | 05.05.2022 | 29.04.2023 | 30.08.2023 | |||||
| Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
| Financial report URL | ||||||||||
| Annual report URL | ||||||||||
| Revenue, bln rub | ? | 0.840 | 1.08 | 1.18 | 1.14 | 1.24 | ||||
| Operating Income, bln rub | 0.180 | 0.200 | 0.120 | 0.111 | 0.151 | |||||
| EBITDA, bln rub | ? | 0.240 | 0.205 | 0.155 | 0.164 | 0.214 | ||||
| Net profit, bln rub | ? | 0.085 | 0.073 | 0.012 | 0.046 | 0.052 | ||||
| OCF, bln rub | ? | 0.176 | 0.054 | 0.280 | 0.220 | 0.225 | ||||
| CAPEX, bln rub | ? | 0.200 | 0.086 | 0.153 | 0.218 | 0.186 | ||||
| FCF, bln rub | ? | -0.045 | 0.041 | 0.066 | -0.042 | -0.028 | ||||
| Dividend payout, bln rub | 0.085 | 0.111 | 0.111 | |||||||
| Dividend, rub/share | ? | 1 | 1.2 | 1.2 | ||||||
| Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 1.6% | 1.2% | 1.1% | ||||
| Dividend payout ratio, % | 0% | 0% | 0% | 185% | 213% | |||||
| OPEX, bln rub | 0.660 | 0.750 | 1.06 | 1.03 | 1.09 | |||||
| Amortization, bln rub | 0.0 | |||||||||
| R&D, bln rub | 0.030 | 0.005 | 0.080 | |||||||
| Employment expenses, bln rub | 0.201 | 0.224 | 0.253 | 0.245 | ||||||
| Interest expenses, bln rub | 0.028 | 0.027 | 0.051 | 0.055 | 0.074 | |||||
| Assets, bln rub | 1.40 | 1.51 | 1.74 | 2.04 | 2.36 | |||||
| Net Assets, bln rub | ? | 0.110 | 0.194 | 0.234 | 0.341 | 0.381 | ||||
| Debt, bln rub | 0.252 | 0.180 | 0.494 | 0.708 | 0.673 | |||||
| Cash, bln rub | 0.090 | 0.100 | 0.193 | 0.202 | 0.362 | |||||
| Net debt, bln rub | 0.16 | 0.08 | 0.30 | 0.51 | 0.00 | 0.31 | ||||
| Ordinary share price, rub | 13.0 | 38.2 | 115.0 | 62.1 | 102.0 | 107.3 | ||||
| Number of ordinary shares, mln | 75.0 | 75.0 | 85.0 | 92.6 | 92.6 | 92.6 | ||||
| Free Float, % | 15.0% | |||||||||
| Market cap, bln rub | 0.97 | 2.86 | 9.78 | 5.75 | 9.45 | 9.94 | ||||
| EV, bln rub | ? | 1.14 | 2.94 | 10.1 | 6.26 | 9.45 | 10.2 | |||
| Book value, bln rub | -0.31 | -0.27 | -0.31 | -0.40 | 0.00 | -0.36 | ||||
| EPS, rub | ? | 1.13 | 0.97 | 0.14 | 0.50 | 0.00 | 0.56 | |||
| FCF/share, rub | -0.60 | 0.55 | 0.78 | -0.45 | 0.00 | -0.30 | ||||
| BV/share, rub | -4.13 | -3.53 | -3.64 | -4.26 | 0.00 | -3.92 | ||||
| EBITDA margin, % | ? | 28.6% | 18.9% | 13.1% | 14.4% | 17.3% | ||||
| Net margin, % | ? | 10.1% | 6.7% | 1.0% | 4.0% | 4.2% | ||||
| FCF yield, % | ? | -4.6% | 1.4% | 0.7% | -0.7% | 0.0% | -0.3% | |||
| ROE, % | ? | 77.3% | 37.6% | 5.1% | 13.5% | 13.6% | ||||
| ROA, % | ? | 6.1% | 4.8% | 0.7% | 2.3% | 2.2% | ||||
| P/E | ? | 11.5 | 39.2 | 814.6 | 125.0 | 191.1 | ||||
| P/FCF | -21.7 | 69.8 | 148.1 | -136.9 | -354.9 | |||||
| P/S | ? | 1.16 | 2.64 | 8.28 | 5.06 | 8.04 | ||||
| P/BV | ? | -3.14 | -10.8 | -31.6 | -14.6 | -27.4 | ||||
| EV/EBITDA | ? | 4.73 | 14.4 | 65.0 | 38.1 | 47.9 | ||||
| Debt/EBITDA | 0.68 | 0.39 | 1.94 | 3.09 | 1.45 | |||||
| R&D/CAPEX, % | 15.00% | 0.00% | 3.27% | 36.70% | 0 | |||||
| CAPEX/Revenue, % | 24% | 8% | 13% | 19% | 15% | |||||
| ABIO shareholders | ||||||||||
